PTK2, known as focal adhesion kinase 1, plays an essential role in regulating focal adhesions, indicating the activation of the focal adhesion pathway by MET.[41] We regard the plasma‐based results may afford information for further study of the distinctive molecular mechanism underlying the intracranial formation and development of BrM and glioma. The gene discussed is PTK2; the disease is central nervous system cancer.